They're some of the most overlooked income investments. I'm willing to bet that nine out of 10 investors don't even consider them when they're buying an income stock...
That's a shame because if you know what to look for, these securities can be some of the most powerful portfolio builders around.
I'm talking about investing in stocks with low dividend yields. I know, it might seem counterintuitive, but sometimes lower-yielding stocks can be better than their high-yield counterparts.
Don't believe me? Consider two stocks, one that pays 5% and another that yields 3%. It seems like a no-brainer to go with the stock that is yielding 5%.
However, if that low-yield stock can appreciate just 3% a year -- while maintaining its 3% yield -- it can outperform a static 5% yielding stock in just three year's time. In ten years, you can double your money with the low-yielding -- but growing -- security.
Top Electric Utility Companies To Buy For 2016: Schlumberger N.V.(SLB)
Schlumberger Limited, together with its subsidiaries, supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industries worldwide. The company?s Oilfield Services segment provides exploration and production services; wireline technology that offers open-hole and cased-hole services; supplies engineering support, directional-drilling, measurement-while-drilling, and logging-while-drilling services; and testing services. This segment also offers well services; supplies well completion services and equipment; artificial lift; data and consulting services; geo services; and information solutions, such as consulting, software, information management system, and IT infrastructure services that support oil and gas industry. Its WesternGeco segment provides reservoir imaging, monitoring, and development services; and operates data processing centers and multiclient seismic library. This segment also offers variou s services include 3D and time-lapse (4D) seismic surveys to multi-component surveys for delineating prospects and reservoir management. The company?s M-I SWACO segment supplies drilling fluid systems to improve drilling performance; fluid systems and specialty tools to optimize wellbore productivity; production technology solutions to maximize production rates; and environmental solutions that manages waste volumes generated in drilling and production operations. Its Smith Oilfield segment designs, manufactures, and markets drill bits and borehole enlargement tools; and supplies drilling tools and services, tubular, completion services, and other related downhole solutions. The company?s Distribution segment markets pipes, valves, and fittings, as well as mill, safety, and other maintenance products. This segment also provides warehouse management, vendor integration, and inventory management services. Schlumberger Limited was founded in 1927 and is based in Houston, Texas.
Advisors' Opinion:- [By Aaron Levitt]
With fracking and advanced drilling techniques becoming the norm — both onshore and off — the firms that do all of that heavy lifting are set to win big over the longer term. And there are none bigger than Halliburton (HAL) and Schlumberger (SLB). Both remain the undisputed kingpins of fracking and oil services.
- [By Editor , DividendChannel.com]
ENB operates in the Oil & Gas Equipment & Services sector, among companies like Schlumberger (SLB), and Enterprise Products Partners L.P. (EPD).
- [By Tyler Crowe]
When it comes to Canadian oil sands, there has been one direction that many a company has followed: toward the exit. Tough economics, as well as a lack of sufficient takeaway capacity, has made oil sands production difficult for oil companies. But where so many other companies see peril, ExxonMobil (NYSE: XOM ) and Schlumberger (NYSE: SLB ) see opportunity. Exxon has held the course on its major Kearl oil sands project and expects it to be up and running in 2015. Also, Schlumberger has just acquired a Canadian company that provides geochemical and fluid analysis to oil sands producers.
- [By David Smith]
A promising partnership
Total outlays for subsea facilities were slightly more than $25 billion in 2011. That number is expected to rocket to about $130 billion by 2020. Among several companies that will benefit from this nearly five-fold growth are Schlumberger (NYSE: SLB ) and Cameron International (NYSE: CAM ) .
Hot Up And Coming Stocks To Own Right Now: Renasant Corporation(RNST)
Renasant Corporation operates as the bank holding company for the Renasant Bank that provides various financial and insurance services to retail and commercial customers. The company offers checking accounts, money market accounts, savings accounts, certificates of deposit, time deposits, individual retirement accounts, and health savings accounts. It also provides commercial, financial, and agricultural loans; construction loans, including loans for the construction of single family residential properties, multi-family properties, and commercial projects; residential mortgage loans; home equity loans or lines of credit; consumer loans; and equipment leasing, as well as safe deposit and night depository facilities. In addition, the company offers various fiduciary services; and administers qualified retirement plans, profit sharing and other employee benefit plans, personal trusts, and estates. Further, the company provides annuities, mutual funds, and other investment ser vices through a third party broker-dealer. Additionally, the company offers commercial and personal insurance products through carriers. As of October 21, 2011, it operated approximately 75 banking, mortgage, financial services, and insurance offices in Mississippi, Tennessee, Alabama, and Georgia. The company was founded in 1904 and is based in Tupelo, Mississippi.
Advisors' Opinion:- [By Rich Duprey]
Financial services specialist�Renasant� (NASDAQ: RNST ) �announced yesterday�its second-quarter dividend of $0.17 per share, the same rate it's paid since 2007.
Hot Up And Coming Stocks To Own Right Now: Thermon Group Holdings Inc.(THR)
Thermon Group Holdings, Inc. offers heat tracing solutions for process industries worldwide. The company?s solutions provide an external heat source to pipes, vessels, and instruments for the purposes of freeze protection, temperature and flow maintenance, environmental monitoring, and surface snow and ice melting. Its products comprise a range of electric heat tracing cables, steam tracing components, and tubing bundles. The company also offers instrument and control products, including self-regulating and power limiting heating cables; mineral insulated cables; heat traced tube bundles for environmental gas sampling systems; heat transfer compounds and steam tracers for steam tracing solutions; control and monitoring systems for electric tracing of pipes, tanks, hoppers, and instrument sampling systems; and hopper heating modules. In addition, it provides various turnkey solutions for heat tracing, such as design, front-end optimization, product supply, engineering deli verables, system integration, installation, commissioning, and maintenance services. The company offers its solutions to the energy, chemical processing, power generation, and industrial and commercial infrastructure, as well as engineering, procurement, and construction companies. It serves customers through a network of sales and service professionals, and distributors in approximately 30 countries. The company is headquartered in San Marcos, Texas.
Advisors' Opinion:- [By Seth Jayson]
Thermon Group Holdings (NYSE: THR ) reported earnings on June 5. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q4), Thermon Group Holdings missed estimates on revenues and missed estimates on earnings per share. - [By CRWE]
Thermon Group Holdings, Inc. (NYSE:THR), will issue a press release reporting its fourth quarter and full fiscal 2012 consolidated financial results before the market opens on Friday, June 1 2012.
Hot Up And Coming Stocks To Own Right Now: Lionbridge Technologies Inc.(LIOX)
Lionbridge Technologies, Inc. provides language, development, and testing services. Its Global Language and Content segment provides product localization services, such as creating foreign language versions of its clients? products and software applications, including the user interface, online help systems, and documentation; and content translation services, such as translating and maintaining clients? Web-based content, eLearning courseware and training materials, technical support, and sales and marketing information. It also offers technical authoring, eLearning courseware development, and production and integration of content; and global language and content services delivery. The company?s Global Development and Testing segment develops and maintains on-premise, SaaS, and smart phone and tablet applications, as well as provides Web production services. This segment also offers various testing services under the VeriTest brand, including managed test teams, test proc ess design, test automation, functional testing, performance testing, globalization testing, and product certification. In addition, it provides specialized search relevance, online content editorial, keyword optimization, and related services. Its Interpretation segment offers interpretation services for government business and healthcare organizations that require experienced linguists to facilitate communication. It provides interpretation communication services, such as onsite interpretation, over-the-phone interpretation and interpreter testing, training, and assessment services in approximately 360 languages and dialects. The company serves the technology, mobile and telecommunications, Internet and media, life sciences, government, manufacturing, automotive, retail, and aerospace sectors in the Americas, Europe, and Asia. Lionbridge Technologies, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Lionbridge Technologies (Nasdaq: LIOX ) , whose recent revenue and earnings are plotted below. - [By Jeff Reeves]
Lionbridge (LIOX) is the kind of cheap, small-cap stock that investors love. This player has soared 60% in the last three months thanks to nice earnings and improving investor sentiment.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Lionbridge Technologies (Nasdaq: LIOX ) , whose recent revenue and earnings are plotted below.
Hot Up And Coming Stocks To Own Right Now: Nikon Corp (NINOY)
NIKON CORPORATION is a Japan-based company mainly engaged in the manufacture and sale of optical products. The Company is active in four business segments. The Precision Apparatus segment offers semiconductor exposure apparatus and liquid crystal (LC) exposure apparatus. The image segment provides digital cameras, film cameras and interchangeable lens. The Instruments segment offers microscopes, measuring machines and semiconductor inspection equipment. The Others segment provides glass materials, telescopes, glasses and survey airplanes.
As of August 19, 2009, the Company held a 92.17% stake in Metis NV. The Company has 65 subsidiaries and 10 associated companies in the country and overseas markets.
Advisors' Opinion:- [By Dan Carroll]
Unfortunately, the yen's impact on stocks has blurred the lines on investments. Look no further than down-on-its-luck camera maker Nikon (NASDAQOTH: NINOY ) . Nikon's shares gained more than 8% over the past week due to the yen's weakness, as the company rakes in more than a quarter of its sales in Europe. Still, the stock's lost more than 43% year to date.
Hot Up And Coming Stocks To Own Right Now: CytRx Corporation(CYTR)
CytRx Corporation, a biopharmaceutical research and development company, engages in the development of human therapeutics, specializing in oncology. Its drug development pipeline includes INNO-206, which is in Phase II clinical trials for the treatment of soft tissue sarcomas and is in Phase Ib/2 clinical trials for the treatment of solid tumors; and tamibarotene that is in Phase II clinical trials for the treatment of non-small-cell lung cancer and acute promyelocytic leukemia. The company also develops Bafetinib, which is in Phase II clinical trials for the treatment of B-cell chronic lymphocytic leukemia and advanced prostate cancer, as well as in pharmacokinetic clinical trial for brain cancer. CytRx Corporation was founded in 1985 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By James E. Brumley]
Quick - what do CytRx Corporation (NASDAQ:CYTR) and Ignyta Inc. (NASDAQ:RXDX) have in common? Yes, they're both biotech stocks, but that's not the absolute best answer right now. The most meaningful common element between RXDX and CYTR right now is, each is on the verge of a big technical breakout and deserves a spot on your watchlist. Here's a closer look at each.�
- [By James Johnson]
CytRx Corporation's (NASDAQ: CYTR ) oncology drug, aldoxorubicin, an improved version of the chemotherapeutic agent doxorubicin, recently received FDA approval to extend the dosing in a Phase 3 clinical trial. This trial is evaluating aldoxorubicin as a second-line treatment for soft-tissue sarcomas (STS). In April 2013, the FDA granted Special Protocol Assessment (SPA) to aldoxorubicin as a second-line treatment for STS with a maximum dosing of six cycles. The drug is given by a 30 minute IV infusion once every three weeks which is one cycle. The extension of the treatment cycle was based on aldoxorubicin's superior cardiac safety and efficacy profile compared to doxorubicin in prior studies. Aldoxorubicin was found to be safer than doxorubicin, a toxic drug associated with side effects such as cardiovascular events and heart damage in cancer patients. The extended dosing could allow CytRx to demonstrate even higher progression-free survival (PFS) efficacy results compared to the Phase 2b trial for advanced STS with this drug. The company plans to initiate the Phase 3 trial during the first quarter of 2014.
- [By Roberto Pedone]
Another under-$10 biotechnology player that's starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.
If you take a look at the chart for CytRx, you'll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock's 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.
Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.
Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.